|
Autistic Disorder
|
0.300 |
Biomarker
|
disease |
CTD_human |
Phosphorylation level of four specific salivary phospho-peptides, namely statherin, histatin 1 (both, p < 0.0001) and acidic proline-rich proteins (both entire and truncated isoforms) (p < 0.005) was found significantly lower in autistic patients, with hypo-phosphorylation of at least one peptide observed in 18 ASD subjects (66%).
|
19367726 |
2008 |
|
Miscarriage
|
0.020 |
Biomarker
|
disease |
BEFREE |
Quantitative fluorescent polymerase chain reaction analysis of maternal and POC DNA for short tandem repeat (STR) markers was used to both monitor maternal cell contamination and confirm the chromosomal status and sex of the miscarriage tissue.
|
25767059 |
2015 |
|
Liver carcinoma
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
The aim of this study was to test the relationship of TCR-gamma STR genetic polymorphisms and hepatocellular carcinoma (HCC).
|
17094402 |
2006 |
|
Inflammatory Bowel Diseases
|
0.020 |
GeneticVariation
|
group |
BEFREE |
The aim of this study was to evaluate whether SLC11A1 has a role in the susceptibility to inflammatory bowel disease (IBD) by characterizing a promoter polymorphism within the gene and two short tandem repeat (STR) markers in genetic proximity to SLC11A1.
|
15757519 |
2005 |
|
Inflammatory Bowel Diseases
|
0.020 |
GeneticVariation
|
group |
BEFREE |
We aimed to define genotype-phenotype relationships and interactions with the IBD susceptibility gene CARD15for various IBD susceptibility loci (IBD1, IBD2, IBD5, IBD6, IBD7, and chromosome 4) by characterizing previously described peak LOD score short tandem repeat (STR) markers.
|
15643611 |
2005 |
|
Liver carcinoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
Multiple STR genetic allelotyping is an effective tool for clear-cut discrimination of donor/recipient origin of a second HCC after OLT.
|
15714062 |
2005 |
|
Miscarriage
|
0.020 |
Biomarker
|
disease |
BEFREE |
Multiplex and simple QF-PCR assays have been performed on 160 miscarriage and 34 parental DNA samples analysing specific short tandem repeat (STR) markers for chromosomes 2, 7, 13, 15, 16, 18, 21, 22 and X.
|
15760965 |
2005 |
|
Hemophilia A
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
Thus, carrier screening and prenatal diagnosis of hemophilia A often depends on haplotype analysis using restriction fragment length polymorphisms (RFLP) and short tandem repeat (STR) markers to track the defective factor VIII gene within a family.
|
12768323 |
2003 |
|
Schizophrenia
|
0.020 |
Biomarker
|
disease |
BEFREE |
To determine if there are common genes that contribute to the susceptibility for schizophrenia, first-stage genome-wide scan was carried out by genotyping 417 short-tandem repeat (STR) markers in 338 individuals from 130 families with 148 affected sib-pairs identified at 16 sites nationwide in Japan.
|
12815734 |
2003 |
|
Hemophilia A
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
The heterozygosities observed for RFLP markers was higher (>70%) than the STR markers (50%) in the affected families with haemophilia A. Inversion mutation was detected in 37% of severely affected patients.
|
12373312 |
2002 |
|
AMYOTROPHY, HEREDITARY NEURALGIC
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
Significant linkage was obtained with chromosome 17q24-q25 short tandem repeat (STR) markers in three HNA families and suggestive linkage was found in the other two HNA families.
|
10602368 |
1999 |
|
AMYOTROPHY, HEREDITARY NEURALGIC
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
Hereditary neuralgic amyotrophy (HNA) is an autosomal dominant recurrent neuropathy mapped to a 4-cM interval on chromosome 17q25 between the short tandem repeat (STR) markers D17S1603 and D17S802.
|
10610718 |
1999 |
|
Schizophrenia
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
This article-one in a series that describes the results of a genome-wide scan with 459 short-tandem repeat (STR) markers for susceptibility loci in the NIMH Genetics Initiative schizophrenia sample-presents results for African-American pedigrees.
|
9674972 |
1998 |
|
Cystic Fibrosis
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Considering the negative screening for rare genetic variants in ADIPOQ and STATH genes, it may be concluded that these genes are not associated with phenotypic modulation of CF in our population.
|
31606405 |
2019 |
|
Malignant neoplasm of lung
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
In this study, 75 lung cancer tissue samples were examined to evaluate the reliability of various STR markers.
|
29154002 |
2018 |
|
Carcinoma of lung
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
In this study, 75 lung cancer tissue samples were examined to evaluate the reliability of various STR markers.
|
29154002 |
2018 |
|
Primary malignant neoplasm of lung
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
In this study, 75 lung cancer tissue samples were examined to evaluate the reliability of various STR markers.
|
29154002 |
2018 |
|
Superficial ulcer
|
0.010 |
Biomarker
|
disease |
BEFREE |
In total, 223 proteins were identified.After treatment with EGCG and CHX gels, proteins with potential functions to protect against caries and erosion such as PRPs, calcium-bind proteins and Statherin were increased.
|
28622550 |
2017 |
|
Pneumocystis jiroveci pneumonia
|
0.010 |
Biomarker
|
disease |
BEFREE |
Genotyping was performed using six already validated short tandem repeat (STR) markers on 249 samples (median: 17 per centre interquartile range [11-20]) from PCP patients of 16 European centres.
|
28705464 |
2017 |
|
Skin Erosion
|
0.010 |
Biomarker
|
disease |
BEFREE |
In total, 223 proteins were identified.After treatment with EGCG and CHX gels, proteins with potential functions to protect against caries and erosion such as PRPs, calcium-bind proteins and Statherin were increased.
|
28622550 |
2017 |
|
Embryonal Rhabdomyosarcoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Loss of heterozygosity (LOH) was evaluated in all CS ERMS by microarray and/or short tandem repeat (STR) markers spanning the entire chromosome 11.
|
27589201 |
2016 |
|
Costello syndrome (disorder)
|
0.010 |
Biomarker
|
disease |
BEFREE |
Loss of heterozygosity (LOH) was evaluated in all CS ERMS by microarray and/or short tandem repeat (STR) markers spanning the entire chromosome 11.
|
27589201 |
2016 |
|
myeloblastosis
|
0.010 |
Biomarker
|
disease |
BEFREE |
Three sets of highly expressed candidate genes-distal-less homeobox 6 (DLX6) for E-ACC; protein keratin 16 (KRT16), SRY box 11 (SOX11), and v-myb avian myeloblastosis viral oncogene homolog (MYB) for M-ACC; and engrailed 1 (EN1) and statherin (STATH), which are common to both E-ACC and M-ACC)-were further validated at the protein level.
|
26953815 |
2016 |
|
Fragile X Syndrome
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
We performed preimplantation genetic diagnosis (PGD) on 595 blastomeres biopsied from 442 cleavage stage embryos at risk for FXS using short tandem repeat (STR) markers.
|
25953684 |
2015 |
|
Triploidy syndrome
|
0.010 |
Biomarker
|
disease |
BEFREE |
Of the two discordant results, a 69,XXX polyploidy was missed by CNV-Seq, although supporting STR marker analysis confirmed the triploidy.
|
25767059 |
2015 |